Work

P-Glycoprotein inhibition at the blood-brain barrier visualized with (R)-[11C]verapamil μPET

Year: 2007

Type: article

Abstract: Address: 1Department of Radiopharmaceuticals, ARC GmbH, Seibersdorf, Austria, 2Department of Clinical Pharmacology, Medical University of Vienna, Austria, 3Department of Medical Computer Sciences, Medical University of Vienna, Austria, 4Department of Nuclear Medicine, Medical University of Vienna, Austria and 5Department of Pharmacology, Toxicology and Pharmacy, School of Veterinary Medicine Hannover, Germany

Source: BMC Pharmacology

DOI: 10.1186/1471-2210-7-s2-a24

Authors: Claudia Kuntner, Jens Bankstahl, Aiman Abrahim, Rudolf Karch, Johann Stanek, Thomas Wanek, Maria Zsebedics, Kurt Kletter, Wolfgang Löscher, Herbert Kvaternik, Markus Müller, Oliver Langer

Institutions: AIT Austrian Institute of Technology GmbH, Seibersdorf Laboratories (Austria), ARC Seibersdorf research GmbH, University of Veterinary Medicine Hannover, Foundation, Medical University of Vienna

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W2080888069

FWCI:

Cites:

Cited by:

Related to: 10